Genentech - The Value of the Right Partner

Courtesy of @cane or should I say CANE

I thought this short video was very interesting and thought provoking and maybe justifies its own thread.





James is the Global Head And Executive Vice President of Roche Partnering, leading the combined groups from Roche and Genentech. He is also a member of the Roche enlarged Corporate Executive Committee. Prior to this he was Senior Vice President of Genentech Partnering. Prior to this, he was President and CEO of Arete Therapeutics as well as Chairman of the Board of Directors and former CEO of Cytokinetics, a company he co-founded in August 1997. He currently sits on Cytokinetics' scientific advisory board. Prior to Cytokinetics, he held faculty positions at the University of California, San Francisco and Harvard Medical School. He serves on the Board of Directors of HopeLab, a not-for-profit organization developing innovative technologies for the management of cancer, obesity and other diseases. He is a former member of Dean’s Council of the Kennedy School of Government at Harvard University and serves on the advisory board of the California Institute of Quantitative Biosciences. He received an M.D. from Queen’s University and a Ph.D. in Neuroscience from the University of California, San Francisco.

His continued interests are in identifying,completing and managing drug discovery and development alliances that focus on novel targets and approaches to managing serious medical illness. In particular, he is interested in approaches that take into consideration the complexity and variation inherent in the human biological processes and putting the drug discovery process in an evolutionary context.